In the wave of precision medicine development, EXCELSIUS Medical, leveraging its profound expertise in optical scanning and laser energy control, has created ophthalmic surgical solutions with highly automated and customized features. Through its self-developed excimer and minimally invasive femtosecond laser technology bases, EXCELSIUS has successfully developed an open platform that integrates diverse corneal data, achieving leading precision in vision correction and cataract surgery. This platform is widely used in clinical refractive treatment and anterior chamber surgery, not only improving the smoothness of medical procedures but also creating crucial digital medical value for both doctors and patients.

At this symposium, EXCELSIUS Medical showcased its R&D capabilities, breaking the technological monopoly of Europe and the United States, attracting significant attention from various investors regarding the localization of high-end medical devices. Daniel Brothers Commercial Platform, with its expertise in commercial legal advice and compliance review, is committed to assisting medical device companies with high technological barriers to accurately connect with biotechnology special funds and accelerate certification processes when facing stringent medical regulations and cross-border market access, jointly advancing the technological boundaries of the global ophthalmic medical industry.